{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:40:44Z","timestamp":1761043244834,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Viral Associated Malignancies"},{"name":"Stiefel Oropharyngeal Research Fund"},{"name":"The University of Texas MD Anderson Cancer Center"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.urolonc.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T22:54:56Z","timestamp":1547679296000},"page":"294.e17-294.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mean treatment cost of incident cases of penile cancer for privately insured patients in the United States"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2285-0527","authenticated-orcid":false,"given":"David R.","family":"Lairson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyaw","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangshuang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen E.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis A.","family":"Pettaway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2019.01.004_bib0001","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1158\/1055-9965.EPI-07-0221","article-title":"Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003","volume":"16","author":"Goodman","year":"2007","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0002","doi-asserted-by":"crossref","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","article-title":"human papillomavirus-associated cancers\u2014United States, 2008-2012","volume":"65","author":"Viens","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0003","first-page":"258","article-title":"Human papillomavirus-associated cancers\u2014United States, 2004-2008","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0004","doi-asserted-by":"crossref","first-page":"791","DOI":"10.21037\/tau.2017.06.27","article-title":"Relationship between human papillomavirus and penile cancer\u2014implications for prevention and treatment","volume":"6","author":"Kidd","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0005","first-page":"449","article-title":"Systematic review of human papillomavirus prevalence in invasive penile cancer","volume":"20","author":"Backes","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0006","first-page":"1","article-title":"Prevalence of HPV in Adults Aged 18 \u2013 69\u202f: United States, 2011-2014","volume":"280","author":"Mcquillan","year":"2017","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0007","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2017","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0008","doi-asserted-by":"crossref","first-page":"784","DOI":"10.15585\/mmwr.mm6429a3","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 Years \u2014 United States, 2014","volume":"64","author":"Reagan-Steiner","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"year":"2000","series-title":"Vaccines for the 21st century: a tool for decisionmaking","key":"10.1016\/j.urolonc.2019.01.004_bib0009"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0010","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1186\/s12889-015-2669-2","article-title":"Penile cancer treatment costs in England","volume":"15","author":"Keeping","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0011","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1186\/1471-2458-12-1082","article-title":"Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark","volume":"12","author":"Olsen","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0012","doi-asserted-by":"crossref","DOI":"10.1186\/1758-3284-4-15","article-title":"The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid","volume":"4","author":"Jacobson","year":"2012","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0013","article-title":"Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas","author":"Fu","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0014","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0895-4356(96)00271-5","article-title":"Practical considerations on the use of the Charlson comorbidity index with administrative data bases","volume":"49","author":"D'Hoore","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00005650-198905000-00009","article-title":"A psychiatric patient classification system\u202f: an alternative to diagnosis-related groups","volume":"27","author":"Ashcraft","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jval.2010.10.006","article-title":"Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003","volume":"14","author":"Cipriano","year":"2017","journal-title":"Value Heal"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0017","unstructured":"Consumer price index-medical care. In: U.S. department of Labor Bureau of Labor Statistics. http:\/\/data.bls.gov\/cgi-bin\/surveymost?cu."},{"key":"10.1016\/j.urolonc.2019.01.004_bib0018","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00345-008-0302-z","article-title":"Penile cancer: epidemiology, pathogenesis and prevention","volume":"27","author":"Bleeker","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0019","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1016\/j.vaccine.2012.07.056","article-title":"Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States","volume":"30","author":"Chesson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.03.064","article-title":"The economic burden of noncervical human papillomavirus disease in the United States","volume":"198","author":"Hu","year":"2008","journal-title":"Am J Obs Gynecol"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0021","article-title":"Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas","author":"Fu","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0022","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1158\/1055-9965.EPI-17-0220","article-title":"Medical care cost of oropharyngeal cancer among texas patients","volume":"26","author":"Lairson","year":"2017","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0023","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ygyno.2017.02.011","article-title":"Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas","volume":"145","author":"Lairson","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0024","first-page":"61","article-title":"National human papillomavirus vaccination coverage among adolescents Aged 13\u201317 Years\u2014National Immunization Survey-Teen, United States, 2011","volume":"63","author":"Curtis","year":"2014","journal-title":"MMWR"},{"key":"10.1016\/j.urolonc.2019.01.004_bib0025","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/SLA.0b013e31826b4c4f","article-title":"A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications","volume":"256","author":"Lawson","year":"2012","journal-title":"Ann Surg"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919300043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919300043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:15:10Z","timestamp":1761041710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143919300043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1078143919300043"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.01.004","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mean treatment cost of incident cases of penile cancer for privately insured patients in the United States","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}